000 01355 a2200409 4500
005 20250516094102.0
264 0 _c20121025
008 201210s 0 0 eng d
022 _a1873-2518
024 7 _a10.1016/j.vaccine.2012.04.087
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVanni, Tazio
245 0 0 _aEconomic modelling assessment of the HPV quadrivalent vaccine in Brazil: a dynamic individual-based approach.
_h[electronic resource]
260 _bVaccine
_cJul 2012
300 _a4866-71 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aBrazil
650 0 4 _aCost-Benefit Analysis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunization Programs
_xeconomics
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aModels, Economic
650 0 4 _aPapillomavirus Infections
_xprevention & control
650 0 4 _aPapillomavirus Vaccines
_xeconomics
650 0 4 _aUterine Cervical Neoplasms
_xprevention & control
650 0 4 _aVaccination
_xeconomics
650 0 4 _aYoung Adult
700 1 _aLuz, Paula Mendes
700 1 _aFoss, Anna
700 1 _aMesa-Frias, Marco
700 1 _aLegood, Rosa
773 0 _tVaccine
_gvol. 30
_gno. 32
_gp. 4866-71
856 4 0 _uhttps://doi.org/10.1016/j.vaccine.2012.04.087
_zAvailable from publisher's website
999 _c21826249
_d21826249